JP2009529059A5 - - Google Patents

Download PDF

Info

Publication number
JP2009529059A5
JP2009529059A5 JP2008558416A JP2008558416A JP2009529059A5 JP 2009529059 A5 JP2009529059 A5 JP 2009529059A5 JP 2008558416 A JP2008558416 A JP 2008558416A JP 2008558416 A JP2008558416 A JP 2008558416A JP 2009529059 A5 JP2009529059 A5 JP 2009529059A5
Authority
JP
Japan
Prior art keywords
phenyl
thiazol
trifluoromethyl
pyridin
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008558416A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009529059A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/006023 external-priority patent/WO2007103550A2/en
Publication of JP2009529059A publication Critical patent/JP2009529059A/ja
Publication of JP2009529059A5 publication Critical patent/JP2009529059A5/ja
Withdrawn legal-status Critical Current

Links

JP2008558416A 2006-03-08 2007-03-08 抗ｃ型肝炎ウイルス活性を有する置換アミノチアゾール誘導体 Withdrawn JP2009529059A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78060906P 2006-03-08 2006-03-08
PCT/US2007/006023 WO2007103550A2 (en) 2006-03-08 2007-03-08 Substituted aminothiazole derivatives with anti-hcv activity

Publications (2)

Publication Number Publication Date
JP2009529059A JP2009529059A (ja) 2009-08-13
JP2009529059A5 true JP2009529059A5 (https=) 2010-03-11

Family

ID=38328551

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008558416A Withdrawn JP2009529059A (ja) 2006-03-08 2007-03-08 抗ｃ型肝炎ウイルス活性を有する置換アミノチアゾール誘導体

Country Status (7)

Country Link
US (1) US20070213301A1 (https=)
EP (2) EP2460800A1 (https=)
JP (1) JP2009529059A (https=)
AU (1) AU2007223797A1 (https=)
CA (1) CA2645072A1 (https=)
NZ (1) NZ570835A (https=)
WO (1) WO2007103550A2 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ563866A (en) * 2005-05-09 2011-03-31 Achillion Pharmaceuticals Inc Thiazole compounds and methods of use
JP5182088B2 (ja) 2006-04-19 2013-04-10 アステラス製薬株式会社 アゾールカルボキサミド誘導体
US8183263B2 (en) * 2007-05-22 2012-05-22 Achillion Pharmaceuticals, Inc. Heteroaryl substituted thiazoles
WO2008154601A1 (en) * 2007-06-12 2008-12-18 Genelabs Technologies, Inc. Anti-viral inhibitors and methods of use
ES2331220B1 (es) * 2007-10-02 2010-09-23 Palobiofarma, S.L. Nuevos compuestos como antagonistas de los receptores a1 de adenosina.
RU2461551C2 (ru) 2007-10-24 2012-09-20 Астеллас Фарма Инк. Азолкарбоксамидное соединение или его фармацевтически приемлемая соль
AU2009256390A1 (en) 2008-06-03 2009-12-10 Siga Technologies, Inc. Small molecule inhibitors for the treatment or prevention of dengue virus infection
US8106209B2 (en) 2008-06-06 2012-01-31 Achillion Pharmaceuticals, Inc. Substituted aminothiazole prodrugs of compounds with anti-HCV activity
US9643922B2 (en) 2008-08-18 2017-05-09 Yale University MIF modulators
PE20110368A1 (es) * 2008-08-18 2011-06-13 Univ Yale Moduladores de mif
US9540322B2 (en) 2008-08-18 2017-01-10 Yale University MIF modulators
US8563742B2 (en) * 2008-08-29 2013-10-22 High Point Pharmaceuticals, Llc Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use
WO2010088573A1 (en) * 2009-01-30 2010-08-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues for preventing or treating hepatitis c infection
US8481483B2 (en) * 2009-02-19 2013-07-09 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8367053B2 (en) * 2009-07-09 2013-02-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8685917B2 (en) * 2009-07-09 2014-04-01 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8349312B2 (en) * 2009-07-09 2013-01-08 Enanta Pharmaceuticals, Inc. Proline substituted cyclosporin analogues
US8623814B2 (en) * 2010-02-23 2014-01-07 Enanta Pharmaceuticals, Inc. Antiviral agents
KR20140071472A (ko) 2011-10-04 2014-06-11 인스티튜트 포 헤퍼타이티스 앤드 바이러스 리서치 간세포 암종을 포함하는 암의 저해제로서 그리고 간염 바이러스 복제의 저해제로서의 치환된 아미노티아졸
WO2014085623A1 (en) 2012-11-28 2014-06-05 Enanta Pharmaceuticals, Inc. Novel [n-me-4-hydroxyleucine]-9-cyclosporin analogues
WO2015031381A1 (en) 2013-08-26 2015-03-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues for preventing or treating hepatitis c
US9669095B2 (en) 2014-11-03 2017-06-06 Enanta Pharmaceuticals, Inc. Cyclosporin analogues for preventing or treating hepatitis C infection

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3467666A (en) * 1966-11-07 1969-09-16 Geigy Chem Corp 2-substituted aminothiazoles
BE795907A (fr) * 1972-02-25 1973-06-18 Luso Farmaco Inst 2-amino-4-arylthiazoles 5-substitues et leur preparation
DE3406329A1 (de) * 1984-02-22 1985-08-22 Merck Patent Gmbh, 6100 Darmstadt Pyridone
EP1302468B1 (en) 1992-12-29 2008-12-17 Abbott Laboratories Processes and intermediates for manufacturing retroviral protease inhibiting compounds
AU689972B2 (en) * 1994-11-29 1998-04-09 Hisamitsu Pharmaceutical Co., Inc. Antibacterial preparation or bactericide comprising 2-aminothiazole derivative and/or salt thereof
US6323180B1 (en) 1998-08-10 2001-11-27 Boehringer Ingelheim (Canada) Ltd Hepatitis C inhibitor tri-peptides
WO2000017175A1 (en) * 1998-09-18 2000-03-30 Vertex Pharmaceuticals Incorporated INHIBITORS OF p38
WO2002059099A1 (en) * 2001-01-26 2002-08-01 Shionogi & Co., Ltd. Cyclic compounds having thrombopoietin receptor agonism
KR100979988B1 (ko) * 2001-08-13 2010-09-03 얀센 파마슈티카 엔.브이. 2-아미노-4,5-삼치환 티아졸릴 유도체
WO2003048140A1 (en) * 2001-12-03 2003-06-12 Japan Tobacco Inc. Azole compound and medicinal use thereof
EP1321463B1 (en) * 2001-12-21 2007-08-08 Virochem Pharma Inc. Thiazole derivatives and their use for the treatment or prevention of Flavivirus infections
CN101723891A (zh) * 2003-02-10 2010-06-09 沃泰克斯药物股份有限公司 通过使n-芳基氨基甲酸酯与卤代杂芳基反应制备n-杂芳基-n-芳基胺的方法和类似方法
TW200505902A (en) * 2003-03-20 2005-02-16 Schering Corp Cannabinoid receptor ligands
CA2547804A1 (en) * 2003-12-08 2005-06-30 F. Hoffmann-La Roche Ag Novel thiazole derivatives
NZ563866A (en) * 2005-05-09 2011-03-31 Achillion Pharmaceuticals Inc Thiazole compounds and methods of use
GB0513702D0 (en) * 2005-07-04 2005-08-10 Sterix Ltd Compound
US8183263B2 (en) * 2007-05-22 2012-05-22 Achillion Pharmaceuticals, Inc. Heteroaryl substituted thiazoles
US20090208550A1 (en) * 2007-10-26 2009-08-20 Cronstein Bruce N Methods and compositions for treating hepatic diseases
US8106209B2 (en) * 2008-06-06 2012-01-31 Achillion Pharmaceuticals, Inc. Substituted aminothiazole prodrugs of compounds with anti-HCV activity

Similar Documents

Publication Publication Date Title
JP2009529059A5 (https=)
ES2534392T3 (es) Inhibidores de la proteína tirosina fosfatasa humana y métodos de uso
HRP20220003T1 (hr) Spojevi derivata 1,3,4-oksadiazola kao inhibitori histonske deacetilaze 6, i farmaceutski pripravak koji ih sadrži
JP5837936B2 (ja) アルキルスルフィニル置換チアゾリド化合物
ES2309862T3 (es) Compuestos que ejercen efecto sobre la glucoquinasa.
RU2013143028A (ru) Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ
RU2009118602A (ru) Производное индола
JP2008526866A5 (https=)
JP2009525285A5 (https=)
CA2684105A1 (en) Pyridine derivatives
JP2010506825A5 (https=)
JP2006077019A5 (https=)
JP2009520825A5 (https=)
JP2010540462A5 (https=)
RU2012116877A (ru) Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы
TWI846853B (zh) 吡咯化合物
JP2017523972A5 (https=)
JP2006506439A5 (https=)
CA2672373A1 (en) Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
CA2536954A1 (en) C-kit modulators and methods of use
JP2018507234A5 (https=)
JP2006507247A5 (https=)
RU2016111138A (ru) Гетероциклические соединения и способы их применения
JPH08509486A (ja) アテローム性動脈硬化症および食事障害の治療についてのチアゾリジンジオンの使用
JP2014513122A5 (https=)